ovarian cancer

Pharma

J&J will appeal $1.5B verdict in record-breaking talc award

In the largest award ever against J&J to a talc plaintiff, a Baltimore jury has ordered the company to pay $1.56 billion to a woman with mesothelioma.

Kevin Dunleavy Dec 23, 2025 11:06am

AZ faces FDA challenge as Imfinzi-Lynparza miss survival goal

Oct 19, 2025 4:15am

ESMO: Merck lays out Keytruda's landmark win in ovarian cancer

Oct 18, 2025 10:30am

In ovarian cancer, Keytruda follows PFS win with survival showing

Oct 16, 2025 10:23am

J&J will appeal $966M award by LA jury in talcum powder lawsuit

Oct 7, 2025 3:20pm

China approves 4 new drugs, including global 1st-in-class

Jul 2, 2025 11:32am